Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COVAGREF: Vaccines Immunogenicity in Transplanted or Candidate Children
NCT03180359Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Jan 2016
- Primary completion
- Oct 2019
- Modality
- Split/Subunit Vaccines, Live Attenuated Vaccines, Recombinant Protein Vaccines
- Countries
- 1
01
Overview
Open-label, single-arm trial of influenza vaccine, varicella virus vaccine live, measles virus vaccine live, tetanus toxoid, Hepatitis A virus vaccine and 1 more in vaccine-preventable diseases (VPDs), sponsored by Hospices Civils de Lyon. Primary endpoint: Immunogenicity of recommended vaccines. Started Jan 2016; status: completed.
02
Drugs
influenza vaccinevaricella virus vaccine livemeasles virus vaccine livetetanus toxoidHepatitis A virus vaccine
03
Conditions
vaccine-preventable diseases (VPDs)
Beyond the preview
Go deeper on NCT03180359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03180359.